- call +1-201-465-4211
- email sales@mrinsights.biz
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
Scope of the Report:
This report studies the Nanomedicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nanomedicine market by product type and applications/end industries.
As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
Potential pipeline of products based on the nanomolecules and associated technologies are anticipated to drive market with potential avenues of growth. Presence of around 40% of products in phase II of clinical development, is anticipated to result in a number of key commercialization over the coming decade influencing revenue generation over the forecast period. The customized treatment options available for eradication of genetic abnormalities also makes this technology a substantial option for precision medicine.
Asia Pacific is expected to witness lucrative growth through to 2025 as a result of rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, rise in the number of venture capital investors from developing economies of this region and increasing international research collaborations are anticipated to propel growth in nanotechnology-based healthcare industry.
The global Nanomedicine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nanomedicine.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Market Segment by Applications, can be divided into
Segmentation encompasses oncology
Infectious diseases
Cardiology
Orthopedics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Nanomedicine Market Overview
1.1 Product Overview and Scope of Nanomedicine
1.2 Classification of Nanomedicine by Types
1.2.1 Global Nanomedicine Revenue Comparison by Types (2017-2023)
1.2.2 Global Nanomedicine Revenue Market Share by Types in 2017
1.2.3 Quantum dots
1.2.4 Nanoparticles
1.2.5 Nanoshells
1.2.6 Nanotubes
1.2.7 Nanodevices
1.3 Global Nanomedicine Market by Application
1.3.1 Global Nanomedicine Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Segmentation encompasses oncology
1.3.3 Infectious diseases
1.3.4 Cardiology
1.3.5 Orthopedics
1.3.6 Others
1.4 Global Nanomedicine Market by Regions
1.4.1 Global Nanomedicine Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Nanomedicine Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Nanomedicine Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanomedicine Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Nanomedicine Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanomedicine Status and Prospect (2013-2023)
1.5 Global Market Size of Nanomedicine (2013-2023)
2 Manufacturers Profiles
2.1 Combimatrix
2.1.1 Business Overview
2.1.2 Nanomedicine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Combimatrix Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.2 Ablynx
2.2.1 Business Overview
2.2.2 Nanomedicine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Ablynx Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abraxis Bioscience
2.3.1 Business Overview
2.3.2 Nanomedicine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abraxis Bioscience Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celgene
2.4.1 Business Overview
2.4.2 Nanomedicine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celgene Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mallinckrodt
2.5.1 Business Overview
2.5.2 Nanomedicine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mallinckrodt Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.6 Arrowhead Research
2.6.1 Business Overview
2.6.2 Nanomedicine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Arrowhead Research Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.7 GE Healthcare
2.7.1 Business Overview
2.7.2 Nanomedicine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GE Healthcare Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Nanomedicine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Nanomedicine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.10 Nanosphere
2.10.1 Business Overview
2.10.2 Nanomedicine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Nanosphere Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.11 Epeius Biotechnologies
2.11.1 Business Overview
2.11.2 Nanomedicine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Epeius Biotechnologies Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.12 Cytimmune Sciences
2.12.1 Business Overview
2.12.2 Nanomedicine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Cytimmune Sciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
2.13 Nanospectra Biosciences
2.13.1 Business Overview
2.13.2 Nanomedicine Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Nanospectra Biosciences Nanomedicine Revenue, Gross Margin and Market Share (2016-2017)
3 Global Nanomedicine Market Competition, by Players
3.1 Global Nanomedicine Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Nanomedicine Players Market Share
3.2.2 Top 10 Nanomedicine Players Market Share
3.3 Market Competition Trend
4 Global Nanomedicine Market Size by Regions
4.1 Global Nanomedicine Revenue and Market Share by Regions
4.2 North America Nanomedicine Revenue and Growth Rate (2013-2018)
4.3 Europe Nanomedicine Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Nanomedicine Revenue and Growth Rate (2013-2018)
4.5 South America Nanomedicine Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Nanomedicine Revenue and Growth Rate (2013-2018)
5 North America Nanomedicine Revenue by Countries
5.1 North America Nanomedicine Revenue by Countries (2013-2018)
5.2 USA Nanomedicine Revenue and Growth Rate (2013-2018)
5.3 Canada Nanomedicine Revenue and Growth Rate (2013-2018)
5.4 Mexico Nanomedicine Revenue and Growth Rate (2013-2018)
6 Europe Nanomedicine Revenue by Countries
6.1 Europe Nanomedicine Revenue by Countries (2013-2018)
6.2 Germany Nanomedicine Revenue and Growth Rate (2013-2018)
6.3 UK Nanomedicine Revenue and Growth Rate (2013-2018)
6.4 France Nanomedicine Revenue and Growth Rate (2013-2018)
6.5 Russia Nanomedicine Revenue and Growth Rate (2013-2018)
6.6 Italy Nanomedicine Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Nanomedicine Revenue by Countries
7.1 Asia-Pacific Nanomedicine Revenue by Countries (2013-2018)
7.2 China Nanomedicine Revenue and Growth Rate (2013-2018)
7.3 Japan Nanomedicine Revenue and Growth Rate (2013-2018)
7.4 Korea Nanomedicine Revenue and Growth Rate (2013-2018)
7.5 India Nanomedicine Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Nanomedicine Revenue and Growth Rate (2013-2018)
8 South America Nanomedicine Revenue by Countries
8.1 South America Nanomedicine Revenue by Countries (2013-2018)
8.2 Brazil Nanomedicine Revenue and Growth Rate (2013-2018)
8.3 Argentina Nanomedicine Revenue and Growth Rate (2013-2018)
8.4 Colombia Nanomedicine Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Nanomedicine by Countries
9.1 Middle East and Africa Nanomedicine Revenue by Countries (2013-2018)
9.2 Saudi Arabia Nanomedicine Revenue and Growth Rate (2013-2018)
9.3 UAE Nanomedicine Revenue and Growth Rate (2013-2018)
9.4 Egypt Nanomedicine Revenue and Growth Rate (2013-2018)
9.5 Nigeria Nanomedicine Revenue and Growth Rate (2013-2018)
9.6 South Africa Nanomedicine Revenue and Growth Rate (2013-2018)
10 Global Nanomedicine Market Segment by Type
10.1 Global Nanomedicine Revenue and Market Share by Type (2013-2018)
10.2 Global Nanomedicine Market Forecast by Type (2018-2023)
10.3 Quantum dots Revenue Growth Rate (2013-2023)
10.4 Nanoparticles Revenue Growth Rate (2013-2023)
10.5 Nanoshells Revenue Growth Rate (2013-2023)
10.6 Nanotubes Revenue Growth Rate (2013-2023)
10.7 Nanodevices Revenue Growth Rate (2013-2023)
11 Global Nanomedicine Market Segment by Application
11.1 Global Nanomedicine Revenue Market Share by Application (2013-2018)
11.2 Nanomedicine Market Forecast by Application (2018-2023)
11.3 Segmentation encompasses oncology Revenue Growth (2013-2018)
11.4 Infectious diseases Revenue Growth (2013-2018)
11.5 Cardiology Revenue Growth (2013-2018)
11.6 Orthopedics Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Nanomedicine Market Size Forecast (2018-2023)
12.1 Global Nanomedicine Market Size Forecast (2018-2023)
12.2 Global Nanomedicine Market Forecast by Regions (2018-2023)
12.3 North America Nanomedicine Revenue Market Forecast (2018-2023)
12.4 Europe Nanomedicine Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Nanomedicine Revenue Market Forecast (2018-2023)
12.6 South America Nanomedicine Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Nanomedicine Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Nanomedicine Picture
Table Product Specifications of Nanomedicine
Table Global Nanomedicine and Revenue (Million USD) Market Split by Product Type
Figur
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
